http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108434457-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6935
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G65-3348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G65-334
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108434457-B
titleOfInvention Adriamycin polyethylene glycol epothilone B conjugate and preparation method thereof
abstract The invention relates to an adriamycin pegylated epothilone B and a preparation method thereof, and the method mainly comprises the following steps: 1) reacting adriamycin with hydrazide polyethylene glycol carboxyl under the action of phosphoric acid to obtain an adriamycin polyethylene glycol carboxyl intermediate, wherein the molar ratio of adriamycin to phosphoric acid is 1: 0.01-0.02; 2) under the action of a second coupling agent and a catalyst, the epothilone B reacts with the adriamycin polyethylene glycol carboxyl intermediate to obtain the adriamycin pegylated epothilone B conjugate.
priorityDate 2018-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107469089-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1881000-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936553
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID56
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496523
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41183
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43359
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40848
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID39130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486422
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID33501
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37888
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35199
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID56
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004

Total number of triples: 51.